产品简要
公司名称 :
HUABIO
产品类型 :
抗体
产品名称 :
前列腺特异抗原重组兔单克隆抗体[SD07-45](ET1612-19)
目录 :
ET1612-19
规格 :
单克隆
价格 :
SD07-45
克隆性 :
单克隆
宿主 :
domestic rabbit
共轭标签 :
未共轭
克隆名称 :
SD07-45
反应物种 :
人类
应用 :
免疫印迹, 免疫细胞化学, 免疫组化-石蜡切片
更多信息或购买 :
产品信息
Catalog# :
ET1612-19
产品名称 :
前列腺特异抗原重组兔单克隆抗体[SD07-45](ET1612-19)
类别 :
Recombinant Rabbit monoclonal primary
共轭 :
未共轭
克隆性 :
单克隆
克隆编号 :
SD07-45
宿主 :
兔
应用 :
免疫印迹, 免疫细胞化学, IF, 免疫组化-P
应用w/稀释 :
WB: 1:1, 000;免疫细胞化学/IF:1:50-1:200;免疫组化-P:1:50-1:200
反应物种 :
人类
免疫原 :
重组蛋白
抗体亚型 :
IgG
靶蛋白 :
前列腺特异抗原
靶标.UniProt数据库 :
P07288
靶标.同义词 :
antigen, prostate-specific antibody; APS antibody; Gamma seminoprotein antibody; Gamma-seminoprotein antibody; hK3 antibody; Kallikrein 3 antibody; Kallikrein related peptidase 3 antibody; Kallikrein-3 antibody; KLK 3 antibody; KLK2A1 antibody; Klk3 antibody; KLK3_HUMAN antibody; P-30 antigen antibody; P30 antigen antibody; Prostate-specific antigen antibody; Psa antibody; Semenogelase antibody; Seminin antibody
Target function/background :
Prostate specific antigen (PSA), also designated γ-seminoprotein, seminin, p30 antigen, semenogelase, and kallikrein 3 (KLK3), was first identified as a glycoprotein in human seminal plasma. PSA was determined by sequence similarity to be a member of the kallikrein subfamily of trypsin proteases. PSA is a serine protease that hydrolyzes the major human seminal protein, the seminal plasma mobility inhibitor precursor, or semenogelin I (SPMIP or SgI), which leads to semen liquification. PSA production and expression are highest in normal, benign hyperplastic and cancerous tissues of the prostate, although PSA has also been detected in accessory male sex glands and in breast cancer. PSA has been identified as an aid in the early detection of prostate cancer and is a commonly used tumor marker.
产品形式 :
液体
纯化 :
蛋白质A亲和纯化
浓度 :
1微克/微升
储存缓冲液 :
1*TBS (pH7.4), 0.05% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
储存空调 :
Store at +4℃ after thawing. Aliquot store at -20℃ or -80℃. Avoid repeated freeze / thaw cycles.
分子量 :
34 kDa
供应商 :
HUABIO
Volume :
100ul
价格 :
355
launch date :
2020&prior
更多信息或购买 :
公司信息
HUABIO
Founded in 2007, HUABIO is dedicated to developing high-quality antibodies that advance innovation. We are passionate about the accuracy, efficiency, and consistency of our products. That is why we have invested in new production platforms, like recombinant rabbit monoclonals, alpaca nanobodies, and adopted aggressive QA standards to deliver cutting-edge antibodies with uncompromised quality.
We hope to see you at your next discovery!
We hope to see you at your next discovery!